EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck

Matthew Carlson, Beverly Wuertz, Jizhen Lin, Randy Taylor, Frank Ondrey

International Journal of Otolaryngology · 2009

DOI: 10.1155/2009/649615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Otolaryngology, 2009. Verfasst von Matthew Carlson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of Minnesota, MMC 396, 420 Delaware ST SE, Minneapolis, MN 55455, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibition (TKI) is a promising treatment in upper aerodigestive malignancies. EGFR inhibitors might be more effective in patients whose tumors harbor specific EGFR mutations. The presence of specific EFGR mutations is predictive of over a 75% response rate to TKI therapies as compared to 10% in wild type cases of non-small cell lung cancer. Our objective was to examine whether these mutations might occur in upper aerodigestive cancers.

Design

DNA was extracted from 20 head and neck squamous cell tumors and 4 squamous cell carcinoma cell lines and sequenced the receptor using published primer pairs. We then compared the results against published mutations.

Results

No exon 19 or 21 mutations were found in any of the 20 tumors and 0 of 4 cell lines. Based on the tumor data we would predict that no greater than 8% of head and neck tumors (CI 97.5%) would be likely to harbor either of these mutations.

Conclusions

Our findings are comparable to results recently published of Korean, Austrian, and Spanish patient populations and we conclude that exon 19 and 21 EGFR mutations are not more common in head and neck cancer than in nonsmall-cell carcinoma.

Autor:innen und Institutionen

  • Department of Otolaryngology, University of Minnesota, MMC 396, 420 Delaware ST SE, Minneapolis, MN 55455, USA.

Zitieren

APA

Carlson, M., Wuertz, B., Lin, J., Taylor, R., & Ondrey, F. (2009). Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck. International Journal of Otolaryngology. https://doi.org/10.1155/2009/649615

Vancouver

Carlson M, Wuertz B, Lin J, Taylor R, Ondrey F. Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck. International Journal of Otolaryngology. 2009. doi:10.1155/2009/649615

BibTeX
@article{Carlson2009,
  author = {Carlson, Matthew and Wuertz, Beverly and Lin, Jizhen and Taylor, Randy and Ondrey, Frank},
  title = {Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck},
  journal = {International Journal of Otolaryngology},
  year = {2009},
  doi = {10.1155/2009/649615}
}
Kostenlos starten →